DIAGNOSTIC UTILITY OF SERUM LIPID PROFILE AND URINARY MICROALBUMIN FOR ASSESSING CARDIO METABOLIC RISK AND EARLY DIABETIC NEPHROPATHY IN TYPE 2 DIABETES MELLITUS
Diabetes mellitus is a chronic metabolic disease interpretive by steady hyperglycemia resulting from impaired insulin secretion, insulin resistance, or both. Dyslipidemia is a common metabolic abnormality associated with T2DM and significantly subsides the development of atherosclerotic cardiovascular disease, leading...